Amgen AMGN Income Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| $8.62B-12.6% | $9.87B+3.2% | $9.56B+4.1% | $9.18B+12.6% | $8.15B-10.3% | ||
| $2.74B-7.8% | $2.98B-3.4% | $3.08B+2.4% | $3.01B+1.4% | $2.97B-4.6% | ||
| $5.87B-14.7% | $6.89B+6.4% | $6.48B+5.0% | $6.17B+19.1% | $5.18B-13.3% | ||
| 68.2%-1.7pp | 69.8%+2.1pp | 67.8%+0.6pp | 67.2%+3.6pp | 63.6%-2.2pp | ||
| $1.72B-19.7% | $2.14B+12.7% | $1.9B+8.9% | $1.74B+17.4% | $1.49B-13.8% | ||
| $1.6B-17.9% | $1.95B+13.5% | $1.72B+1.7% | $1.69B+0.2% | $1.69B-10.2% | ||
| $1.12B-1.4% | $1.13B-13.4% | $1.31B-2.5% | $1.34B-3.3% | $1.39B-0.7% | ||
| $5.95B-16.7% | $7.15B+1.6% | $7.03B+7.8% | $6.52B-6.4% | $6.97B+2.9% | ||
| $2.67B-2.0% | $2.72B+7.7% | $2.53B-4.9% | $2.66B+125% | $1.18B-49.0% | ||
| 30.9%+3.4pp | 27.6%+1.1pp | 26.4%-2.5pp | 28.9%+14.5pp | 14.5%-11.0pp | ||
| $657M+0.6% | $653M-4.7% | $685M-1.3% | $694M-4.0% | $723M-3.2% | ||
| $75M— | —— | $2.08B+628% | -$394M-126% | $1.52B— | ||
| $2.08B+37.6% | $1.51B-61.4% | $3.92B+150% | $1.57B-20.5% | $1.97B+152% | ||
| $265M+46.4% | $181M-74.3% | $705M+418% | $136M-44.0% | $243M+56.8% | ||
| $1.82B+36.5% | $1.33B-58.6% | $3.22B+125% | $1.43B-17.2% | $1.73B+176% | ||
| 21.1%+7.6pp | 13.5%-20.1pp | 33.7%+18.0pp | 15.6%-5.6pp | 21.2%+14.3pp | ||
| $3.34+35.8% | $2.46-58.5% | $5.93+124% | $2.65-17.2% | $3.20+176% | ||
| $3.37+36.4% | $2.47-58.7% | $5.98+125% | $2.66-17.4% | $3.22+175% | ||
| 544M+0.4% | 542M0.0% | 542M+0.2% | 541M0.0% | 541M0.0% | ||
| 540M+0.4% | 538M0.0% | 538M0.0% | 538M0.0% | 538M+0.2% | ||
| $0— | —— | $400M— | —— | $800M+2,567% | ||
| $67M+127% | -$250M-993% | $28M+21.7% | $23M-54.0% | $50M+31.6% | ||
| -$143M— | —— | $1.97B— | —— | $1.3B+248% | ||
| -$176M-826% | -$19M+36.7% | -$30M+92.9% | -$422M-68.8% | -$250M+25.1% | ||
| $571M— | —— | —— | $589M+18.5% | $497M— | ||
| -$413M-138% | $1.08B— | $0-100% | $515M-60.6% | $1.31B+377% | ||
| $71M+119% | -$365M— | —— | -$2.42B-2,424% | $104M— | ||
| -$959M-228% | $749M+475% | -$200M-124% | $824M+194% | -$874M-220% | ||
| -$18M+84.9% | -$119M+50.4% | -$240M-0.4% | -$239M+17.0% | -$288M+10.8% | ||
| $71M-5.3% | $75M+1.4% | $74M-19.6% | $92M+31.4% | $70M— | ||
| -$8M-101% | $577M+104% | $283M+37.4% | $206M+2.5% | $201M+1,336% | ||
| -$75M+1.3% | -$76M-660% | -$10M— | $0+100% | -$78M— | ||
| -$839M— | —— | $1.18B+88.8% | $627M+29.0% | $486M-26.1% | ||
| $657M+0.6% | $653M-4.7% | $685M-1.3% | $694M-4.0% | $723M-3.2% | ||
| $1.44B+217% | -$1.23B+57.0% | -$2.85B-6.7% | -$2.67B+34.9% | -$4.11B-192% | ||
| -$716M-3.3% | -$693M-67.4% | -$414M-6.4% | -$389M+13.0% | -$447M-11.2% | ||
| $2.19B+36.6% | $1.6B-65.8% | $4.68B+105% | $2.28B+63.9% | $1.39B-70.8% | ||
| $67M+127% | -$250M-993% | $28M+21.7% | $23M-54.0% | $50M+31.6% | ||
| -$113M— | —— | —— | —— | $830M— | ||
| $4M— | —— | —— | $20M-44.4% | $36M— | ||
| $1.36B+5.8% | $1.28B+0.1% | $1.28B+0.2% | $1.28B+0.1% | $1.28B+6.1% | ||
| $712M+10.9% | $642M+47.2% | $436M+18.2% | $369M-10.2% | $411M+10.8% | ||
| $3.96B— | —— | —— | —— | $0— | ||
| -$104M— | —— | —— | -$92M-241% | -$27M-1,250% | ||
| $833M— | $0-100% | $1.5B+50.0% | $1B-60.0% | $2.5B— | ||
| $1.72B-19.7% | $2.14B+12.7% | $1.9B+8.9% | $1.74B+17.4% | $1.49B-13.8% | ||
| $8.62B-12.6% | $9.87B+3.2% | $9.56B+4.1% | $9.18B+12.6% | $8.15B-10.3% | ||
| $75M-40.0% | $125M-1.6% | $127M-19.1% | $157M+84.7% | $85M-36.6% | ||
| $2.67B-2.0% | $2.72B+7.7% | $2.53B-4.9% | $2.66B+125% | $1.18B-49.0% | ||
| $3.78B-1.8% | $3.85B+0.5% | $3.83B-4.1% | $4B+55.8% | $2.57B-30.8% | ||
| $3.78B-1.8% | $3.85B+0.5% | $3.83B-4.1% | $4B+55.8% | $2.57B-30.8% | ||
| 43.9%+4.8pp | 39%-1.1pp | 40.1%-3.4pp | 43.5%+12.1pp | 31.5%-9.3pp | ||
| $2.67B-2.0% | $2.72B+7.7% | $2.53B-4.9% | $2.66B+125% | $1.18B-49.0% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What is Amgen's revenue?
- Amgen (AMGN) generated $37.2B in revenue over the trailing twelve months, up 9.1% year over year.
- Is Amgen profitable?
- Amgen reported $7.8B in net income over the trailing twelve months, a 21.0% net margin.
- What are Amgen's profit margins?
- Gross margin is 68.3% and operating margin is 28.4%, with a 21.0% net margin.
- What is Amgen's earnings per share?
- Amgen's diluted EPS over the trailing twelve months is $14.38.
- Where does Amgen's income statement data come from?
- Every line is extracted from Amgen's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
